Moderna shines on vaccine effectiveness
Shares of Moderna (MRNA) build on strong gains on Monday as the company says its booster appears to be effective against the new rapidly spreading Omicron variant, coming out on the top of the ranking against its competitors.
Live prices on most popular markets
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.